Pegaspargase — Drug Intelligence | 13 EU Trials

Filter these 13 trials by condition, phase, country and more.

Open in Search →

13 Registered trials

4 Recruiting

6 Completed trials

12 Sponsors

22 Countries

Phase III

Phase II

Phase III: 7 Phase II/III: 1 Phase II: 4 Phase IV: 1

Oversight events:

2 serious breaches 1 corrective measure across 3 trials

View oversight register →

Sponsors using this IMP

Charite Universitaetsmedizin Berlin KöR 2 Amgen Inc. 1 Assistance Publique Hopitaux De Paris 1 Fondazione Gimema Franco Mandelli Onlus 1 Goethe University Frankfurt 1 Medical University Of Lodz 1 Medical University Of Silesia Katowice Poland 1 Pfizer Inc. 1 Semmelweis University 1 Universita Degli Studi Di Milano Bicocca 1 Universitaetsklinikum Muenster AöR 1 Universitaetsklinikum Schleswig-Holstein 1

All trials

13 total

IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending

2023-509392-17-00 Phase III 11 countries Charite Universitaetsmedizin Berlin KöR
ALLIC 2022 international clinical investigation for advanced management of childhood acute lymphoblastic leukemia Pending

2024-513824-41-00 Phase IV 4 countries Semmelweis University
CAALL-F01: a French protocol for the treatment of acute lymphoblastic leukemia (ALL) in children and adolescents Pending

2024-514243-29-01 Phase III 1 country Assistance Publique Hopitaux De Paris
A Ph2 Superiority Study with InO Monotherapy vs ALLR3 for Induction Treatment of Childhood HR ALL Recruiting

2023-509810-13-00 Phase II 16 countries Pfizer Inc.
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting

2024-518316-39-00 Phase II/III 1 country Medical University Of Lodz
A multicenter, single-arm phase II study to assess the safety, tolerability, and efficacy of Isatuximab in adult patients with cytologic or … Recruiting

2023-507899-47-00 Phase II 1 country Goethe University Frankfurt
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Phase III 14 countries Universitaetsklinikum Muenster AöR
Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended

2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
A Randomized Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults … Ended

2023-503640-14-00 Phase III 17 countries Amgen Inc.
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Phase III 1 country Medical University Of Silesia Katowice Poland
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Ended

2023-509856-32-00 Phase III 5 countries Universitaetsklinikum Schleswig-Holstein
International Study for Treatment of High Risk Childhood Relapsed ALL 2010 - A randomized Phase II Study Conducted by the Resistant Disease … Ended

2024-513070-21-00 Phase II 11 countries Charite Universitaetsmedizin Berlin KöR
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Phase III 12 countries Universita Degli Studi Di Milano Bicocca

Showing 1–13 of 13 trials

← All drugs A–Z